Skip to content

Corpowell: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Corpowell

BE 0742.572.315
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€506,242
2024 · €252,710-€758,952
Equity
€1.8m
2024 · €268,539+€1.5m
Cash
€402,186
2024 · €60,641+€341,545
Balance sheet total
€3.4m
2024 · €2.1m+€1.3m

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€375,772

    up €375,772 (+44.6%), from €842,134 to €1.2m

  • Cash +€341,545

    up €341,545 (+563.2%), from €60,641 to €402,186

    mainly Contributions, distributions and other (+€2.0m) and Depreciation (+€80,109)

  • Deferred charges and accrued income +€336,532

    up €336,532 (+1807.1%), from €18,623 to €355,155

  • Formation expenses +€115,803

    new in 2025: €115,803

  • Intangible fixed assets +€115,010

    up €115,010 (+205.6%), from €55,926 to €170,936

Equity and liabilities
  • Contributions +€2.0m

    up €2.0m (+1290.3%), from €155,000 to €2.2m

  • Profit (loss) carried forward -€506,546

    down €506,546, from €14,068 to -€492,478

  • Trade debts -€220,216

    down €220,216 (-13.1%), from €1.7m to €1.5m

Income statement
  • Gross operating margin -€687,372

    down €687,372, from €304,223 to -€383,149

  • Depreciation +€43,225

    up €43,225 (+117.2%), from €36,884 to €80,109

  • Staff costs +€34,445

    new in 2025: €34,445

  • Financial income +€32,976

    up €32,976 (+492.8%), from €6,692 to €39,668

  • Other operating charges +€18,616

    up €18,616 (+1098.2%), from €1,695 to €20,311

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €252,710
Gross operating margin -€687,372
Staff costs -€34,445
Depreciation -€43,225
Other operating charges -€18,616
Other operating items -€256
Financial income +€32,976
Financial charges -€16,860
Taxes +€8,846
Result 2025 -€506,242

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€1.4m
Investment -€277,957
Financing +€2.0m
Cash 2024 €60,641
Net result for the year -€506,242
Depreciation +€80,109
Stocks and contracts -€375,772
Receivables within one year -€23,748
Deferred charges and accrued income -€336,532
Trade debts -€220,216
Tax, wage and social debts +€4,949
Investment in fixed assets (net) -€277,957
Debts after one year -€9,746
Current portion of long-term debt -€561
Short-term financial debts +€7,262
Contributions, distributions and other +€2.0m
Cash 2025 €402,186
Every line side by side 53 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,098,003 €3,373,449 +€1.3m +60.8%
Formation expenses 20 - €115,803 +€115,803
Fixed assets 21/28 €267,160 €349,205 +€82,045 +30.7%
Intangible fixed assets 21 €55,926 €170,936 +€115,010 +205.6%
Tangible fixed assets 22/27 €211,235 €174,584 -€36,651 -17.4%
Plant, machinery and equipment 23 €7,177 €6,522 -€655 -9.1%
Furniture and vehicles 24 €578 €2,448 +€1,870 +323.7%
Other tangible fixed assets 26 €203,480 €165,614 -€37,866 -18.6%
Financial fixed assets 28 - €3,686 +€3,686
Current assets 29/58 €1,830,843 €2,908,441 +€1.1m +58.9%
Amounts receivable after more than one year 29 €95,000 €95,000 = 0.0%
Other amounts receivable 291 €95,000 €95,000 = 0.0%
Stocks and contracts in progress 3 €842,134 €1,217,906 +€375,772 +44.6%
Stocks 30/36 €842,134 €1,217,906 +€375,772 +44.6%
Amounts receivable within one year 40/41 €814,446 €838,193 +€23,748 +2.9%
Trade receivables 40 €773,122 €707,467 -€65,655 -8.5%
Other amounts receivable 41 €41,323 €130,726 +€89,403 +216.3%
Cash at bank and in hand 54/58 €60,641 €402,186 +€341,545 +563.2%
Deferred charges and accrued income 490/1 €18,623 €355,155 +€336,532 +1807.1%
Total equity and liabilities 10/49 €2,098,003 €3,373,449 +€1.3m +60.8%
Equity 10/15 €268,539 €1,762,297 +€1.5m +556.3%
Contributions 10/11 €155,000 €2,155,000 +€2.0m +1290.3%
Reserves 13 €99,470 €99,775 +€304 +0.3%
Tax-exempt reserves 132 €99,470 €99,775 +€304 +0.3%
Profit (loss) carried forward 14 €14,068 -€492,478 -€506,546
Amounts payable 17/49 €1,829,465 €1,611,151 -€218,313 -11.9%
Amounts payable after more than one year 17 €129,368 €119,622 -€9,746 -7.5%
Financial debts 170/4 €129,368 €119,622 -€9,746 -7.5%
Amounts payable within one year 42/48 €1,700,097 €1,491,530 -€208,567 -12.3%
Current portion of amounts payable after more than one year 42 €10,308 €9,746 -€561 -5.4%
Financial debts 43 €1,239 €8,501 +€7,262 +586.1%
Credit institutions 430/8 €1,239 €8,501 +€7,262 +586.1%
Trade debts 44 €1,676,064 €1,455,848 -€220,216 -13.1%
Suppliers 440/4 €1,676,064 €1,455,848 -€220,216 -13.1%
Taxes, remuneration and social security 45 €12,486 €17,435 +€4,949 +39.6%
Taxes 450/3 €12,486 €11,580 -€906 -7.3%
Remuneration and social security 454/9 - €5,855 +€5,855
Non-recurring operating income 76A - €40,797 +€40,797
Remuneration, social security and pensions 62 - €34,445 +€34,445
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €36,884 €80,109 +€43,225 +117.2%
Other operating charges 640/8 €1,695 €20,311 +€18,616 +1098.2%
Non-recurring operating charges 66A - €256 +€256
Gross operating margin 9900 €304,223 -€383,149 -€687,372
Operating profit (loss) 9901 €265,644 -€518,271 -€783,914
Financial income 75/76B €6,692 €39,668 +€32,976 +492.8%
Recurring financial income 75 €6,692 €39,668 +€32,976 +492.8%
Financial charges 65/66B €7,411 €24,271 +€16,860 +227.5%
Recurring financial charges 65 €7,411 €24,271 +€16,860 +227.5%
Profit (loss) for the period before taxes 9903 €264,924 -€502,874 -€767,798
Income taxes 67/77 €12,214 €3,367 -€8,846 -72.4%
Profit (loss) for the period 9904 €252,710 -€506,242 -€758,952
Transfer to tax-exempt reserves 689 €99,470 €304 -€99,166 -99.7%
Profit (loss) for the period to be appropriated 9905 €153,240 -€506,546 -€659,786

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.